Schedule 13G ownership disclosure

OXFORD IMMUNOTEC GLOBAL PL

Security class unavailable · CUSIP: G6855A103

Event date: 2014-04-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,070,995
Percent of class
6.0800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001425738-15-000011
Form type
SC 13G
Filer
Oxford Immunotec Global PLC
CIK
CIK 1586049
Filed
Feb 18, 2015
Reporting period
Apr 28, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub